Descriptor: "Lipids" / Journal: practice nurse / Topic: therapeutics - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Lipids"' showing total 4 results

Start Over Descriptor "Lipids" Topic therapeutics Journal practice nurse

Author: Sains, Katherine
Subjects: *CARDIOVASCULAR disease prevention, *FISH oils, *NIACIN, *ANTILIPEMIC agents, *CLOFIBRIC acid, *EZETIMIBE, *DRUG interactions, *DRUG monitoring, *HYPERLIPIDEMIA, *LIVER function tests, *MEDICAL office nursing, *PRIMARY health care, *WORLD Wide Web, *INFORMATION resources, *DECISION making in clinical medicine, *STATINS (Cardiovascular agents), *THERAPEUTICS
Abstract: The article presents guidelines for practice nurses in Great Britain involving prescribing for lipid modification. According to the National Institute for Health and Clinical Excellence (NICE), simvastatin is the first-line lipid-lowering treatment. Liver function should be measured to check if statins have increased liver enzymes. Alternative drugs for lipid modification are ezetimibe, fibrates, bile acid sequestrants and Omega-3 fish oils.
Published: 2011

Author: Sains, Katherine
Subjects: *CARDIOVASCULAR disease prevention, *ENZYME inhibitors, *ANTILIPEMIC agents, *CLOFIBRIC acid, *EZETIMIBE, *CARDIOVASCULAR diseases risk factors, *DECISION making, *HIGH density lipoproteins, *HYPERLIPIDEMIA, *LOW density lipoproteins, *TYPE 2 diabetes, *PATIENTS, *TRIGLYCERIDES, *WORLD Wide Web, *INFORMATION resources, *RELATIVE medical risk, *ACUTE coronary syndrome, *PREVENTION, *THERAPEUTICS
Abstract: The article discusses why and for whom lipid-lowering drugs should be prescribed. It explores clinical guidelines published by the British National Institute for Health and Clinical Excellence (NICE) in 2008 that address the prescribing of lipid-lowering agents. The guidance states that statins remain the first-line therapy in most cases in patients who are at high risk of a cardiovascular event, unless they are not tolerated. Lipid-lowering drugs for secondary prevention include ezetimibe, fibrates, nicotinic acid and bile acid sequestrants.
Published: 2011

Author: Warren, Ed
Subjects: *ANTICOAGULANTS, *CEREBROVASCULAR disease prevention, *BRAIN disease treatment, *INFLUENZA prevention, *PLATELET aggregation inhibitors, *CEREBROVASCULAR disease, *CHOLESTEROL, *CLINICAL medicine, *EXERCISE, *HYPERTENSION, *IMMUNIZATION, *WORLD Wide Web, *INFORMATION resources, *TRANSIENT ischemic attack, *KEY performance indicators (Management), *SYMPTOMS, *THERAPEUTICS
Abstract: The article discusses the Quality and Outcomes Framework (QOF) indicators for stroke. It describes the epidemiology of stroke in Great Britain, including the rate of mortality associated with stroke. An explanation of the different QOF indicators for stroke is provided, such as confirmation of diagnosis, blood pressure, lipids level, antiplatelet/anticoagulant therapy and influenza immunization.
Published: 2011

Author: Turner, Alison
Subjects: *LIPIDS, *TYPE 2 diabetes treatment, *PEOPLE with diabetes, *CARDIAC arrest, *STATINS (Cardiovascular agents), *PLACEBOS, *CORONARY disease, *THERAPEUTICS
Abstract: Focuses on lipid lowering treatment for type 2 diabetics. Risk of developing a first cardiac event in patients; Criteria that must be met by patients to participate in the Collaborative Atorvastatin in Diabetes Study; Effectiveness of atorvastatin with placebo for reducing the risk of coronary heart disease.
Published: 2005

Books, media, physical & digital resources

Searchworks